Principles of Liver Preservation

Transplantation of the Liver: Third Edition

Volumn , Issue , 2015, Pages 582-599

  Petrowsky, Henrik ^a,b,c,d   Clavien, Pierre Alain ^d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Department of Visceral and Transplant Surgery ^*  (Switzerland)

^c Section of Hepatobiliary and Pancreatic Surgery   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943375245     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0268-8.00044-0     Document Type: Chapter

References (141)

1. Belzer F.O., Southard J.H. Organ preservation and transplantation. Prog Clin Biol Res 1986, 224:291-303.
2. Briceno J., Marchal T., Padillo J., et al. Influence of marginal donors on liver preservation injury. Transplantation 2002, 74:522-526.
3. Markin R.S., Wisecarver J.L., Radio S.J., et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993, 56:1403-1409.
4. Taneja C., Prescott L., Koneru B. Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells. Transplantation 1998, 65:167-172.
5. Fukumori T., Ohkohchi N., Tsukamoto S., et al. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999, 67:195-200.
6. McCormack L., Dutkowski P., El-Badry A.M., et al. Liver transplantation using fatty livers: always feasible?. J Hepatol 2011, 54:1055-1062.
7. McCormack L., Petrowsky H., Jochum W., et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007, 246:940-946. discussion 6-8.
8. Selzner N., Selzner M., Jochum W., et al. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006, 44:694-701.
9. Ijaz S., Winslet M.C., Seifalian A.M. The effect of consecutively larger doses of L-arginine on hepatic microcirculation and tissue oxygenation in hepatic steatosis. Microvasc Res 2009, 78:206-211.
10. Spitzer A.L., Lao O.B., Dick A.A., et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010, 16:874-884.
11. Baccarani U., Adani G.L., Isola M., et al. Steatosis of the graft is a risk factor for posttransplantation biliary complications. Transplant Proc 2009, 41:1313-1315.
12. Durand F., Renz J.F., Alkofer B., et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008, 14:1694-1707.
13. Diamant A.L., Babey S.H., Wolstein J., et al. Obesity and diabetes: two growing epidemics in California. Policy Brief UCLA Cent Health Policy Res 2010, 1-12.
14. Nguyen D.M., El-Serag H.B. The epidemiology of obesity. Gastroenterol Clin North Am 2010, 39:1-7.
15. Wertheim J.A., Petrowsky H., Saab S., et al. Major challenges limiting liver transplantation in the United States. Am J Transplant 2011, 11:1773-1784.
16. Cywes R., Mullen J.B., Stratis M.A., et al. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation 1993, 56:316-323.
17. de Vera M.E., Lopez-Solis R., Dvorchik I., et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009, 9:773-781.
18. Ho K.J., Owens C.D., Johnson S.R., et al. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation 2008, 85:1588-1594.
19. Hong J.C., Yersiz H., Kositamongkol P., et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg 2011, 146:1017-1023.
20. Cameron A.M., Ghobrial R.M., Yersiz H., et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006, 243:748-753. discussion 53-55.
21. Dutkowski P., Oberkofler C.E., Slankamenac K., et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 2011, 254:745-753. discussion 53.
22. Rana A., Hardy M.A., Halazun K.J., et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008, 8:2537-2546.
23. Villa R., Fondevila C., Erill I., et al. Real-time direct measurement of human liver allograft temperature from recovery to transplantation. Transplantation 2006, 81:483-486.
24. Kaplan J.H., Kenney L.J. Temperature effects on sodium pump phosphoenzyme distribution in human red blood cells. J Gen Physiol 1985, 85:123-136.
25. Low P.S., Bada J.L., Somero G.N. Temperature adaptation of enzymes: roles of the free energy, the enthalpy, and the entropy of activation. Proc Natl Acad Sci U S A 1973, 70:430-432.
26. Taylor M. Biology of cell survival in the cold: the basis for biopreservation of tissue and organs. Advances in biopreservation 2007, 15-62. Boca Raton, Fla: CRC/Taylor & Francis. J.C. Baust, J.M. Baust (Eds.).
27. Engerson T.D., McKelvey T.G., Rhyne D.B., et al. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest 1987, 79:1564-1570.
28. Prasad M.R., Popescu L.M., Moraru, et al. Role of phospholipases A2 and C in myocardial ischemic reperfusion injury. Am J Physiol 1991, 260:H877-H883.
29. Schwertz D.W., Halverson J., Isaacson T., et al. Alterations in phospholipid metabolism in the globally ischemic rat heart: emphasis on phosphoinositide specific phospholipase C activity. J Mol Cell Cardiol 1987, 19:685-697.
30. Ikeda T., Yanaga K., Kishikawa K., et al. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992, 16:454-461.
31. Zhu J., Wang S., Bie P., et al. Apoptosis and regeneration of sinusoidal endothelial cells after extended cold preservation and transplantation of rat liver. Transplantation 2007, 84:1483-1491.
32. Nishimura Y., Romer L.H., Lemasters J.J. Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: the pH paradox and cytoprotection by glucose, acidotic pH, and glycine. Hepatology 1998, 27:1039-1049.
33. Sammut I.A., Thorniley M.S., Simpkin S., et al. Impairment of hepatic mitochondrial respiratory function following storage and orthotopic transplantation of rat livers. Cryobiology 1998, 36:49-60.
34. Clavien P.A., Sanabria J.R., Upadhaya A., et al. Evidence of the existence of a soluble mediator of cold preservation injury. Transplantation 1993, 56:44-53.
35. Doeppner T.R., Grune T., de Groot H., et al. Cold-induced apoptosis of rat liver endothelial cells: involvement of the proteasome. Transplantation 2003, 75:1946-1953.
36. Calmus Y., Cynober L., Dousset B., et al. Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology 1995, 108:1510-1516.
37. Upadhya A.G., Harvey R.P., Howard T.K., et al. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology 1997, 26:922-928.
38. Mulivor A.W., Lipowsky H.H. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrix metalloproteinase activity with doxycycline. Microcirculation 2009, 16:657-666.
39. Topp S.A., Upadhya G.A., Strasberg S.M. Cold preservation of isolated sinusoidal endothelial cells in MMP 9 knockout mice: effect on morphology and platelet adhesion. Liver Transpl 2004, 10:1041-1048.
40. Upadhya G.A., Topp S.A., Hotchkiss R.S., et al. Effect of cold preservation on intracellular calcium concentration and calpain activity in rat sinusoidal endothelial cells. Hepatology 2003, 37:313-323.
41. Kohli V., Gao W., Camargo C.A., et al. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci U S A 1997, 94:9354-9359.
42. Totsukali E., Fung J.J., Ishizawa Y., et al. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology 2004, 51:1413-1416.
43. Horie Y., Wolf R., Anderson D.C., et al. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J Clin Invest 1997, 99:781-788.
44. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
45. Moon K.H., Hood B.L., Mukhopadhyay P., et al. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008, 135:1344-1357.
46. Malhi H., Gores G.J., Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43:S31-S44.
47. Gujral J.S., Bucci T.J., Farhood A., et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 2001, 33:397-405.
48. Fu X., Kassim S.Y., Parks W.C., et al. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001, 276:41279-41287.
49. Okamoto T., Akaike T., Nagano T., et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys 1997, 342:261-274.
50. Hernandez-Barrantes S., Toth M., Bernardo M.M., et al. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 2000, 275:12080-12089.
51. Ra H.J., Parks W.C. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007, 26:587-596.
52. Brule S., Charnaux N., Sutton A., et al. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 2006, 16:488-501.
53. van Golen R.F., van Gulik T.M., Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 2012, 52:1382-1402.
54. Rubio-Gayosso I., Platts S.H., Duling B.R. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006, 290:H2247-H2256.
55. Hattori R., Hamilton K.K., Fugate R.D., et al. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989, 264:7768-7771.
56. Khandoga A., Biberthaler P., Enders G., et al. P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. Shock 2002, 18:529-535.
57. Upadhya G.A., Strasberg S.M. Platelet adherence to isolated rat hepatic sinusoidal endothelial cells after cold preservation. Transplantation 2002, 73:1764-1770.
58. Wang Y.I., Li G., Zhang Y., et al. The expression of von Willebrand factor, soluble thrombomodulin, and soluble p-selectin during orthotopic liver transplantation. Transplant Proc 2007, 39:172-175.
59. Weyrich A.S., Buerke M., Albertine K.H., et al. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 1995, 57:45-55.
60. Clavien P.A., Harvey P.R., Sanabria J.R., et al. Lymphocyte adherence in the reperfused rat liver: mechanisms and effects. Hepatology 1993, 17:131-142.
61. Clavien P.A., Morgan G.R., Sanabria J.R., et al. Effect of cold preservation on lymphocyte adherence in the perfused rat liver. Transplantation 1991, 52:412-417.
62. El-Wahsh M., Seifalian A.M., Fuller B.J., et al. Induction of adhesion molecule expression in liver ischaemia-reperfusion injury is associated with impaired hepatic parenchymal microcirculation. Br J Surg 2004, 91:1034-1039.
63. Takei Y., Marzi I., Gao W.S., et al. Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat. Transplantation 1991, 51:959-965.
64. Rentsch M., Post S., Palma P., et al. Anti-ICAM-1 blockade reduces postsinusoidal WBC adherence following cold ischemia and reperfusion, but does not improve early graft function in rat liver transplantation. J Hepatol 2000, 32:821-828.
65. Rothlein R., Dustin M.L., Marlin S.D., et al. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986, 137:1270-1274.
66. Zhai Y., Petrowsky H., Hong J.C., et al. Ischaemia-reperfusion injury in liver transplantation - from bench to bedside. Nat Rev Gastroenterol Hepatol 2013, 10:79-89.
67. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
68. Huang H., Evankovich J., Yan W., et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011, 54:999-1008.
69. Johnson G.B., Brunn G.J., Kodaira Y., et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002, 168:5233-5239.
70. Schaefer L., Babelova A., Kiss E., et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005, 115:2223-2233.
71. Scheibner K.A., Lutz M.A., Boodoo S., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281.
72. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005, 79:505-514.
73. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
74. Shen X.D., Gao F., Ke B., et al. Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation. Liver Transpl 2005, 11:1273-1281.
75. Tsung A., Hoffman R.A., Izuishi K., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005, 175:7661-7668.
76. Zhai Y., Shen X.D., O'Connell R., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004, 173:7115-7119.
77. Bamboat Z.M., Balachandran V.P., Ocuin L.M., et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010, 51:621-632.
78. Shen X.D., Ke B., Zhai Y., et al. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 2002, 74:315-319.
79. Zwacka R.M., Zhang Y., Halldorson J., et al. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997, 100:279-289.
80. Shen X., Wang Y., Gao F., et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009, 50:1537-1546.
81. Leo R., Pratico D., Iuliano L., et al. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation 1997, 95:885-891.
82. Calne R.Y., Pegg D.E., Pryse-Davies J., et al. Renal Preservation by Ice-Cooling: An Experimental Study Relating to Kidney Transplantation from Cadavers. Br Med J 1963, 2:651-655.
83. Fujita S., Hamamoto I., Nakamura K., et al. Isolated perfusion of rat livers: effect of temperature on O2 consumption, enzyme release, energy store, and morphology. Nihon Geka Hokan 1993, 62:58-70.
84. Hertl M., Chartrand P.B., West D.D., et al. The effects of hepatic preservation at 0 degrees C compared to 5 degrees C: influence of antiproteases and periodic flushing. Cryobiology 1994, 31:434-440.
85. Belzer F.O., Southard J.H. Principles of solid-organ preservation by cold storage. Transplantation 1988, 45:673-676.
86. Collins G.M., Bravo-Shugarman M., Terasaki P.I. Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet 1969, 2:1219-1222.
87. Todo S., Nery J., Yanaga K., et al. Extended preservation of human liver grafts with UW solution. JAMA 1989, 261:711-714.
88. Bretschneider H.J., Hubner G., Knoll D., et al. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975, 16:241-260.
89. Budny T.B., Spiegel H.U. Hans Jurgen Bretschneider: German surgical research pioneer. J Invest Surg 2008, 21:169-170.
90. Eghtesad B., Aucejo F., Fung J.J. Preservation solutions in liver transplantation: what are the options?. Liver Transpl 2006, 12:196-198.
91. Menasche P., Termignon J.L., Pradier F., et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994, 8:207-213.
92. Marshall V.C., Ross H., Scott D.F., et al. Preservation of cadaveric renal allografts-comparison of flushing and pumping techniques. Proc Eur Dial Transplant Assoc 1977, 14:302-309.
93. Stewart Z.A., Cameron A.M., Singer A.L., et al. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009, 9:286-293.
94. Cavallari A., Cillo U., Nardo B., et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003, 9:814-821.
95. Erhard J., Lange R., Scherer R., et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994, 7:177-181.
96. Garcia-Gil F.A., Serrano M.T., Fuentes-Broto L., et al. Celsior versus University of Wisconsin preserving solutions for liver transplantation postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study. World J Surg 2011, 35:1598-1607.
97. Meine M.H., Zanotelli M.L., Neumann J., et al. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation. Transplant Proc 2006, 38:1872-1875.
98. Feng L., Zhao N., Yao X., et al. Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl 2007, 13:1125-1136.
99. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
100. Zager R.A., Baltes L.A., Sharma H.M., et al. Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 1984, 26:689-700.
101. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000, 232:155-162.
102. Ricciardi R., Schaffer B.K., Kim R.D., et al. Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. Transplantation 2001, 72:406-412.
103. Sindram D., Rudiger H.A., Upadhya A.G., et al. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol 2002, 36:78-84.
104. Yin D.P., Sankary H.N., Chong A.S., et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998, 66:152-157.
105. Peralta C., Hotter G., Closa D., et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997, 25:934-937.
106. Peralta C., Hotter G., Closa D., et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999, 29:126-132.
107. Amador A., Grande L., Marti J., et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007, 7:2180-2189.
108. Azoulay D., Del Gaudio M., Andreani P., et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 2005, 242:133-139.
109. Cescon M., Grazi G.L., Grassi A., et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006, 12:628-635.
110. Franchello A., Gilbo N., David E., et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant 2009, 9:1629-1639.
111. Jassem W., Fuggle S., Thompson R., et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver Transpl 2009, 15:1750-1765.
112. Jassem W., Fuggle S.V., Cerundolo L., et al. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006, 81:169-174.
113. Koneru B., Fisher A., He Y., et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005, 11:196-202.
114. Koneru B., Shareef A., Dikdan G., et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007, 7:2788-2796.
115. Degli Esposti D., Sebagh M., Pham P., et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis 2011, 2:e111.
116. Klein M., Geoghegan J., Wangemann R., et al. Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 1999, 67:1128-1132.
117. Bogetti D., Sankary H.N., Jarzembowski T.M., et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 2005, 19:507-511.
118. Kotsch K., Ulrich F., Reutzel-Selke A., et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008, 248:1042-1050.
119. Baskin-Bey E.S., Washburn K., Feng S., et al. Clinical trial of the Pan-Caspase Inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 2007, 7:218-225.
120. Busuttil R.W., Lipshutz G.S., Kupiec-Weglinski J.W., et al. rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant 2011, 11:786-797.
121. Lang J.D., Teng X., Chumley P., et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007, 117:2583-2591.
122. Butler A.J., Rees M.A., Wight D.G., et al. Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation 2002, 73:1212-1218.
123. Imber C.J., St Peter S.D., Lopez de Cenarruzabeitia I., et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002, 73:701-709.
124. Schon M.R., Kollmar O., Wolf S., et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001, 233:114-123.
125. St Peter S.D., Imber C.J., Lopez I., et al. Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg 2002, 89:609-616.
126. Fondevila C., Hessheimer A.J., Maathuis M.H., et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg 2011, 254:1000-1007.
127. Jamieson R.W., Zilvetti M., Roy D., et al. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation 2011, 92:289-295.
128. Nagrath D., Xu H., Tanimura Y., et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng 2009, 11:274-283.
129. Fondevila C., Hessheimer A.J., Ruiz A., et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 2007, 7:1849-1855.
130. Reddy S., Greenwood J., Maniakin N., et al. Non-heart-beating donor porcine livers: the adverse effect of cooling. Liver Transpl 2005, 11:35-38.
131. Reddy S.P., Bhattacharjya S., Maniakin N., et al. Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion. Transplantation 2004, 77:1328-1332.
132. Kamada N., Calne R.Y., Wight D.G., et al. Orthotopic rat liver transplantation after long-term preservation by continuous perfusion with fluorocarbon emulsion. Transplantation 1980, 30:43-48.
133. Pienaar B.H., Lindell S.L., Van Gulik T., et al. Seventy-two-hour preservation of the canine liver by machine perfusion. Transplantation 1990, 49:258-260.
134. Tamaki T., Kamada N., Wight D.G., et al. Successful 48-hour preservation of the rat liver by continuous hypothermic perfusion with haemaccel-isotonic citrate solution. Transplantation 1987, 43:468-471.
135. Guarrera J.V., Estevez J., Boykin J., et al. Hypothermic machine perfusion of liver grafts for transplantation: technical development in human discard and miniature swine models. Transplant Proc 2005, 37:323-325.
136. Lee C.Y., Jain S., Duncan H.M., et al. Survival transplantation of preserved non-heart-beating donor rat livers: preservation by hypothermic machine perfusion. Transplantation 2003, 76:1432-1436.
137. de Rougemont O., Breitenstein S., Leskosek B., et al. One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death. Ann Surg 2009, 250:674-683.
138. Dutkowski P., Furrer K., Tian Y., et al. Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg 2006, 244:968-976. discussion 76-77.
139. Guarrera J.V., Henry S.D., Samstein B., et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010, 10:372-381.
140. Guarrera J.V., Henry S.D., Chen S.W., et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 2011, 167:e365-e373.
141. Dutkowski P., Schlegel A., de Oliveira M., et al. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol 2014, 60:765-772.